SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-091383
Filing Date
2023-08-14
Accepted
2023-08-14 16:24:11
Documents
14
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323741d1_8k.htm   iXBRL 8-K 31549
2 EXHIBIT 99.1 tm2323741d1_ex99-1.htm EX-99.1 111304
6 GRAPHIC tm2323741d1_ex99-1img001.jpg GRAPHIC 4100
  Complete submission text file 0001104659-23-091383.txt   335341

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA azyo-20230814.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE azyo-20230814_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azyo-20230814_pre.xml EX-101.PRE 22353
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2323741d1_8k_htm.xml XML 3442
Mailing Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904
Business Address 12510 PROSPERITY DRIVE SUITE 370 SILVER SPRING MD 20904 240-247-1143
AZIYO BIOLOGICS, INC. (Filer) CIK: 0001708527 (see all company filings)

IRS No.: 474790334 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39577 | Film No.: 231170725
SIC: 2836 Biological Products, (No Diagnostic Substances)